The Essential Role of Body Weight in Adjusting Gn Dosage to Prevent High Ovarian Response for Women With PCOS During IVF: A Retrospective Study
Polycystic ovarian syndrome (PCOS) is the major cause of anovulatory infertility. Since women with PCOS are often accompanied by increased body weight and hyper response to controlled ovarian stimulation, individualized gonadotropin (Gn) dose is required to achieve a therapeutic effect while minimiz...
Main Authors: | Rujun Zeng, Hanxiao Chen, Xun Zeng, Lang Qin |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-07-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2022.922044/full |
Similar Items
-
Effects of different gonadotropin preparations in GnRH antagonist protocol for patients with polycystic ovary syndrome during IVF/ICSI: a retrospective cohort study
by: Zhengyan Hu, et al.
Published: (2024-02-01) -
Follicular-Phase GnRH Agonist Protocol Is Another Choice for Polycystic Ovary Syndrome Patients With Lower LH/FSH and Lower AMH Levels Without Increasing Severe OHSS Risk
by: Rui Gao, et al.
Published: (2022-06-01) -
A modified GnRH antagonist method in combination with letrozole, cabergoline, and GnRH antagonist for PCOS: Safe and effective ovarian stimulation to treat PCOS and prevent OHSS
by: Yasuho Yanagihara, et al.
Published: (2022-01-01) -
Strong Evidences of the Ovarian Carcinoma Risk in Women after IVF Treatment: A Review Article
by: Dariush D. FARHUD, et al.
Published: (2019-12-01) -
Effectiveness, Flexibility and Safety of Switching IVF to IVM as a Rescue Strategy in Unexpected Poor Ovarian Response for PCOS Infertility Patients
by: Wei Guo, et al.
Published: (2023-03-01)